Dr Louise Lim
Medical Oncologist
- Barts Health NHS Trust
United Kingdom (UK)
Dr. Farah Louise Lim is a Medical Oncologist at St Bartholomew’s Cancer centre, London, where she leads the lung cancer clinical trials unit.
Her research focuses on novel therapies for early- and late-stage lung cancer, particularly antibody–drug conjugates (ADCs) and bispecific antibodies, alongside the development of biomarkers to guide therapy selection and improve patient outcomes.
Dr Louise Lim has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
AstraZeneca, Astellas, BMS, Gilead, MSD, Merck-Serono, Pfizer & Roche.
Programmes developed by Dr Louise Lim
Conference update
Oncology
Highlights from ESMO 2026
Experts join us at ESMO 2026 to share their insights on new data on GI, liver, lung, breast and GU cancers
Experts
Dr Elizabeth Smyth, Dr Yelena Janjigian, Assoc. Prof. Gerald Prager, Prof. Hong Jae Chon, Assoc. Prof. Lorenza Rimassa, Dr Tom Newsom-Davis, Dr Louise Lim, Dr Komal Jhaveri, Dr Roberto IacovelliEndorsed by
-
3 MIN
-
Oct 2026
-
3 MIN
Oct 2026 
Oncology
The evolving TROP2-directed ADC landscape in metastatic NSCLC
Strategies to optimise the treatment experience
Experts
Prof. Nicolas Girard, Dr Louise Lim, Dr Jacob Sands, Mrs Stephanie McDonaldEndorsed by
-
Downloadable
Resources -
58 MIN
-
May 2026
-
Downloadable 